HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Recurrence prevention of papillomas of the bladder using lycurim instillation].

Abstract
Following surgical removal of papillary tumours of the bladder from 60 patients the authors performed short instillations of the bladder with LYCURIM. The histological picture revealed tumours in the stage O-A-B1 and grade I-II-III. In a control group (n = 129) 89 recidive cases were observed in 2 years. Out of the 60 patients of the LYCURIM group 19 (31.7%) were free of tumours for 2 years and 43 (71.7%) for 11/2 years. A transient cystitis which occurred with short application of the medicament was easily cured. Toxic effects on the blood picture were not observed.
AuthorsB Zárandy, J Szabó, I Molnár, Z Sallai, Z Simon, J Légrády
JournalZeitschrift fur Urologie und Nephrologie (Z Urol Nephrol) Vol. 77 Issue 10 Pg. 599-603 (Oct 1984) ISSN: 0044-3611 [Print] Germany
Vernacular TitleRezidivprophylaxe von Papillomen der Harnblase mittels Lycurim-Instillation.
PMID6549094 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Erythritol
  • ritrosulfan
Topics
  • Administration, Topical
  • Adult
  • Aged
  • Antineoplastic Agents (administration & dosage)
  • Combined Modality Therapy
  • Erythritol (administration & dosage, analogs & derivatives)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local (prevention & control)
  • Neoplasm Staging
  • Papilloma (drug therapy, pathology)
  • Urinary Bladder Neoplasms (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: